Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Structure Therapeutics Inc
Recent news which mentions Structure Therapeutics Inc
Eli Lilly's obesity pill remains a viable rival to Novo's oral Wegovy despite data that underwhelmed investors
August 24, 2025
Tags
AstraZeneca PLC
US: News
Structure Therapeutics Inc
From
CNBC.com News
Eli Lilly's weight loss pill succeeds in first late-stage trial on diabetes patients
April 17, 2025
Tags
Biotechnology
Health & Science
Health care industry
From
CNBC.com News
Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
March 24, 2025
Tags
Roche Holding AG
Business News
Business
From
CNBC.com News
Healthy Returns: AbbVie is the newest potential weight loss drug market player
March 04, 2025
Tags
GE HealthCare Technologies Inc
Zealand Pharma A/S
Social issues
From
CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
May 07, 2024
Tags
AstraZeneca PLC
Structure Therapeutics Inc
US: News
From
CNBC.com News
The weight loss drug market may soon get more crowded – here are the companies trying to enter the booming space
January 17, 2024
Tags
US: News
Structure Therapeutics Inc
AstraZeneca PLC
From
CNBC.com News
The weight loss drug boom isn't over yet — here's what to expect in the year ahead
December 17, 2023
Tags
Health & Science
Biotechnology
Pfizer Inc
From
CNBC.com News
Shares of biotech startup Structure Therapeutics surge more than 30% on promising obesity pill data
September 29, 2023
Tags
Biotechnology
Biotech and Pharmaceuticals
Breaking news
From
CNBC.com News
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.